巨星傳奇(06683.HK)擬啟動「樂遊上海尋找周同學」活動
巨星傳奇(06683.HK)宣布,周杰倫「嘉年華」世界巡迴演唱會上海收官站將於今年10月舉行,集團將聯合上海久事文化傳播,於9月13日起啟動以周杰倫官方二次元IP形象為核心的「樂遊上海尋找周同學」活動。
該活動是上海旅遊節活動的重要組成部分,以及周杰倫演唱會上海站的延伸活動,將於9月13日至10月12日完整覆蓋上海旅遊節及周杰倫上海演唱會全程,圍繞「6大場景+水陸空聯動+N多品牌跨界」打造多視角文旅盛事。
公司表示,2023年周杰倫在上海舉辦為期四天演唱會帶動門票收入達2億元人民幣,直接帶動上海餐飲、住宿、購物、旅遊消費達32億元人民幣,預期是次活動將為上海文旅經濟增長注入新動能。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.